American Society of Hematology Selects 31 Medical Students and Residents for 2017 HONORS Award

American Society of Hematology's picture
Printer-friendly versionPrinter-friendly version

Published on: July 13, 2017

(WASHINGTON, July 13, 2017) – The American Society of Hematology (ASH) today announced the names of 18 medical students and 13 residents selected to receive the 2017 HONORS Award.

The ASH HONORS Award aims to support the career development of talented North American medical students and residents interested in hematology. Recipients receive a stipend of $5,000 to conduct hematology research projects either in the short-term (up to three months) or long-term (between three and 12 months) and $1,000 each year for two years to support their attendance at a program orientation at the ASH annual meeting. Each HONORS participant will have an ASH member research mentor who will assist and oversee the awardee’s work and progress.

“ASH is proud to support these talented hematologists early in their research careers,” said ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. “We encourage these award recipients to continue research careers in hematology beyond medical school and residency and look forward to watching their careers develop.

The 2017 ASH HONORS Award recipients are:

Medical Students:

RecipientsResearch Topics

Akshaya Arjunan, BS

UPMC Medical Education

Pittsburgh, PA 

Health care utilization and pain management before and after pediatric to adult transition of care in sickle cell disease

Allison Kirkpatrick, BA

University of Maryland

College Park, MD

MCL-1 reduction as a key molecular mechanism of the anti-leukemic activity of artemisinins

Andrew Simmerman, BM

Washington University/ Barnes-Jewish Hospital / St. Louis Children’s Hospital Consortium

St. Louis, MO

The role of DNA hypomethylation in acute myeloid leukemia mediated by DNMT3A loss

Ashley Paquin, BA
College of Medicine, Mayo Clinic

Rochester, MN

Survival and outcome of transplant-eligible patients with multiple myeloma

Calvin Harberg, BS
Medical College of Wisconsin Affiliated Hospitals

Milwaukee, WI

Reactive oxygen species as downstream signaling partners of CD36 in platelets

Charlotte Story, BS

University of North Carolina Hospitals

Chapel Hill, NC

Effect HLA phenotypes on long term graft-versus-host disease risk

Christopher Sande, BMus, BS, MMus

University of Iowa Hospitals and Clinics
Iowa City, IA 

Epidemiology & risk factors for inhibitor development in persons with hemophilia A: A national study

Colleen Flanagan, BA

University of Massachusetts

Worcester, MA

Evaluation of the immunogenicity of the mutant CALR C-terminus expressed in a majority of JAK2wt

myeloproliferative neoplasms patients

Eamon Duffy, MD

Yale-New Haven Medical Center

New Haven, CT

The cell-mediated response to a novel influenza vaccine strategy in patients with plasma cell disorders

Erik Bao, BS

Boston Children's Hospital

Boston, MA

Dissecting the genetic architecture of human hematopoiesis

Jordan Spradbrow, BSc

Queen's University

Kingston, ON, Canada

Use of bleeding assessment tools in the diagnosis of von Willebrand disease: Are we asking the right questions?

Josiah To, MASc, BS

The Chicago Medical School at Rosalind Franklin University of Medicine and Science

North Chicago, IL 

Defining the impact of JAK2 V617F myeloproliferative neoplasms cells on their bone marrow stromal microenvironment

Kathryn Ivy, BA

Boston University School of Medicine

Boston, MA

Investigating the response to IDH1 inhibition in mutant IDH1 acute myeloid leukemia

Monica Chelius, BS

Dartmouth - Hitchcock Medical Center

Lebanon, NH

Very low dose radiotherapy for indolent lymphomas of the head/neck regions: predictors of response and assessment of toxicity

Nicholas Jackson Chornenki, BSc

McMaster University

Hamilton, ON, Canada

The real world practice of treating patients with polycythemia vera

Nikeshan Jeyakumar, MHS

University of Miami Miller School of Medicine

Miami, FL

Assessing the effect of ethnicity on CAR T-cell treatment outcomes

Phillip Staibano, BSc, MSc

University of Ottawa

Ottawa, ON, Canada

Usage of patient-centered outcomes in the management of anemia: A systematic review

Steven Hwang, BS

University of Michigan

Ann Arbor, MI

Role of polypyrimidine tract binding protein 1 in the oncogenesis of anaplastic large cell lymphoma

 

Residents:

RecipientsResearch Topics

Amrita Goyal, MD

University of Minnesota

Minneapolis, MN

Referral patterns and prognostic markers in mycosis fungoides

Andrea Cervi-Charron, MD, MSc

McMaster University

Hamilton, ON, Canada

Pharmacy hydroxyurea education materials for sickle cell disease: An environmental scan and assessment of accuracy

Anthony Sabulski, MD

Cincinnati Children's Hospital Medical Center

Cincinnati, OH

Fidelity of treatment response in a patient-derived xenograft leukemia avatar system

Cesar Gentille Sanchez, MD

Houston Methodist Hospital

Houston, TX

ESCAPEade. Incidence of antibiotic resistant infections and association with mortality in hematological malignancies

Chi-Joan How, MD

Washington University/B-JH/SLCH Consortium

St. Louis, MO

Prognostic significance of minimal residual disease in patients with secondary acute myeloid leukemia

Christina Abrams, BS, MD

University of Tennessee

Knoxville, TN

Abnormal FEF25-75% identifies asthma in sickle cell disease

Daniel Choi, MD

Albert Einstein College of Medicine

Bronx, NY

Hepatocyte growth factor/MET pathway inhibition in myeloproliferative neoplasms

Jessica El-Asmar, MD

Cleveland Clinic Foundation

Cleveland, OH

Prognosis and outcomes of adult acute myeloid leukemia in the contemporary era

Julia Xu, MD, MS

Duke University Hospital

Durhan NC

Thalassemia screening in migrants in Thailand

Katie McQueen, MD

Greenville Health System

Greenville, SC

Heart rate variability biofeedback: A patient-centered therapy for chronic pain and other symptoms of sickle cell disease

Maximilian Stahl, MD

Yale-New Haven Medical Center

New Haven, CT

The use of immunosuppressive treatment in patients with myelodysplastic syndrome: Outcomes and their clinical and molecular predictors in a large patient cohort

Nikita Baclig, MD, MPH

University of Washington

Seattle, WA

Retrospective analysis of outpatient management for adults with acute myeloid leukemia and myelodysplastic syndrome undergoing intensive (re-)induction chemotherapy

Yan Xu, BSc, MD

University of Toronto

Toronto, ON, Canada

Oral anticoagulant-related major bleeding definitions: comparison and assessment of significance

 


The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal. 

Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

3 + 1 =

To prevent automated spam submissions leave this field empty.